Publication | Closed Access
26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life
26
Citations
0
References
1997
Year
MedicineRandomised TrialCancer ManagementPathologyCancer TreatmentOncologyRadiation OncologyLung Cancer
No additional data available for this publication yet. Check back later!